Breakthroughs in ES-SCLC Care: What Immunotherapy Means for Patient Outcomes

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Science

Share Breakthroughs in ES-SCLC Care: What Immunotherapy Means for Patient Outcomes

Sign up to save your podcasts

Breakthroughs in ES-SCLC Care: What Immunotherapy Means for Patient Outcomes

Breakthroughs in ES-SCLC Care: What Immunotherapy Means for Patient Outcomes

More shows like PeerVoice Heart & Lung Video

PeerVoice Brain Behaviour Audio

PeerVoice Oncology & Haematology Audio

PeerVoice Oncology & Haematology Video

PeerVoice Endocrinology & Metabolic Disorders Audio

PeerVoice Digestive Diseases Audio

PeerVoice Digestive Diseases Video

PeerVoice Immunology & Infectious Disease Video

PeerVoice Immunology & Infectious Disease Audio

PeerVoice Internal Medicine Audio

PeerVoice Internal Medicine Video